Schrödinger is a sponsor of and will be presenting at CHI's Ninth Annual Structure-Based Drug Design conference, taking place June 4–5 in Cambridge, MA. Dr. Woody Sherman, Schrödinger's Vice President of Applications Science, will give a presentation titled "Application of Free Energy Perturbation Calculations in Drug Discovery."